ÈÈÃű¬ÁÏ

ÈÈÃű¬ÁÏ. (1).
ASH Letter to FDA re Draft Guidance on Decentralized Clinical Trials.
Retrieved from /advocacy/testimony-and-correspondence/ash-letter-to-fda-re-draft-guidance-on-decentralized-clinical-trials.

ÈÈÃű¬ÁÏ.
"ASH Letter to FDA re Draft Guidance on Decentralized Clinical Trials." Hematology.org.
/advocacy/testimony-and-correspondence/ash-letter-to-fda-re-draft-guidance-on-decentralized-clinical-trials
(label-accessed April 04, 2025).

"ÈÈÃű¬ÁÏ."
ASH Letter to FDA re Draft Guidance on Decentralized Clinical Trials, 04 Apr. 2025 ,
/advocacy/testimony-and-correspondence/ash-letter-to-fda-re-draft-guidance-on-decentralized-clinical-trials.

Citation Manager Formats

• BibLaTeX
• Bookends
• EasyBib
• EndNote
• Mendeley
• Papers
• RIS
• Ref Manager
• RefWorks
• Zotero